Latest Press Releases

Esaote Presents the New Portable Ultrasound System MyLab C30 at the European Congress of Radiology

VIENNA, Feb. 28, 2025 (GLOBE NEWSWIRE) -- A newborn ultrasound series designed with a clear project in mind: ease-of-use, maximum portability and cleanability, together with the excellence in image quality. It is MyLabC-Series, the new portable ...

Philips Expands Cloud-based Enterprise Imaging Services to Europe for Better Access to AI-Enabled Workflows and Innovation

February 27, 2025 Accelerating cloud adoption across Europe with Philips HealthSuite Imaging cloud services on Amazon Web Services Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, ...

KFNCCC Welcomes Georgina Rodríguez's Visit to Support Young Cancer Patients

RIYADH, Saudi Arabia, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The King Fahad National Centre for Children’s Cancer (KFNCCC), a subsidiary of the King Faisal Specialist Hospital and Research Centre (KFSHRC), in collaboration with the Spanish ...

Law Partners Calls for Independent Inquiry Into Deaths at Latrobe Regional Hospital

MELBOURNE, Australia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Michael Passaro, a Managing Solicitor at Law Partners in Victoria has written a letter to Mary-Anne Thomas, Victoria’s Minister for Health, calling for an independent inquiry into recently ...

Philips Accelerates Precise Imaging with Unique AI Technologies in MRI to Improve Patient Outcomes

February 26, 2025 Philips integrates advanced AI algorithms into its MRI systems, featuring Dual AI-driven engines in SmartSpeed Precise [1] to enable faster scanning Innovations include the latest AI-enabled MR Workspace software to ...

OMass Therapeutics appoints Birgitte Volck as Non-Executive Director

OMass Therapeutics appoints Birgitte Volck as Non-Executive Director Oxford, United Kingdom – 26 February 2025 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ...

The Paradoxical Role of Lkb1 in Tumorigenesis

A brief overview of the physiological and pathological role of LKB1 signaling. Mutations in serine-threonine kinase 11 (STK11) and liver kinase B1 (LKB1) are associated with disease progression in Peutz-Jeghers syndrome (PJS), which can progress to ...

New Hope for Colorectal Cancer Treatment: Innovative Ce6-GFFY Photosensitizer Shows Promise in Fighting Tumors

Research reveals promising advancements of Ce6-GFFY in colorectal cancer treatment. Colorectal cancer (CRC) is a highly malignant disease that readily metastasizes to vital organs. Many strategies have been employed for clinical CRC therapy. ...

Challenges in Recruiting Disability Support Workers

In order to help people with impairments live independent, satisfying lives, the disability support industry is essential. However, the lack of skilled and motivated disability assistance workers is a major issue facing the sector. Both people ...

Teledyne e2v Announces New High-speed Sensor with Extended Sensitivity in NIR Wavelengths

GRENOBLE, France, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Teledyne e2v, a Teledyne Technologies [NYSE: TDY] company and global innovator of imaging solutions, introduces Lince5M™ NIR , a state-of-the-art high-speed CMOS image sensor. Leveraging ...

Women of Global Change Malaysia: Pioneering Education, Health, and Empowerment for a Brighter Future

PR Newswire KUALA LUMPUR, Malaysia, Feb. 28, 2025 The Women of Global Change Malaysia chapter, led by Chapter President Anne Tham, is dedicated to empowering communities through education, healthcare initiatives, and sustainable projects. By ...

Supporting community-led responses to the illegal toxic drug and overdose crisis

Canada NewsWire THUNDER BAY, ON, Feb. 28, 2025 Funding will prioritize urgent needs at community level THUNDER BAY, ON, Feb. 28, 2025 /CNW/ - No community has been left untouched by the toxic drug and overdose crisis. Its tragic impacts ...

Increasing supports for residents of Northwest Territories to quit smoking

Canada NewsWire YELLOWKNIFE, NT, Feb. 28, 2025 YELLOWKNIFE, NT, Feb. 28, 2025 /CNW/ - Tobacco use remains a significant preventable cause of premature death in Canada, with approximately 46,000 people dying from tobacco-related illnesses ...

Gov. DeSantis announces $2 million to expand access to FIU personalized cancer treatment technology

PR Newswire MIAMI, Feb. 28, 2025 MIAMI, Feb. 28, 2025 /PRNewswire/ -- Gov. Ron DeSantis on Friday announced $2 million in funding from the Casey DeSantis Florida Cancer Innovation Fund, to increase patients' access to FIU cancer researcher ...

Supporting a community-led response to the illegal toxic drug and overdose crisis in Northwestern Ontario

Canada NewsWire THUNDER BAY, ON, Feb. 28, 2025 THUNDER BAY, ON, Feb. 28, 2025 /CNW/ - The illegal toxic drug supply and overdose crisis is having tragic impacts on communities throughout Canada. Our family, friends and neighbours have been ...

Avirmax Biopharma Initiates IND-enabling Studies of ABI-201; a Breakthrough Gene Therapy for Dry Age-related Macular Degeneration

PR Newswire HAYWARD, Calif., Feb. 28, 2025 HAYWARD, Calif., Feb. 28, 2025 /PRNewswire/ -- Avirmax Biopharma, Inc., a leader in developing the next generation of AAV gene therapies, today announced the commencement of Investigational New Drug ...

BNCT Market Booms with 38.7% CAGR - A Game-Changer in Cancer Treatment | Valuates Reports

PR Newswire BANGALORE, India, Feb. 28, 2025 Boron Neutron Capture Therapy (BNCT) Market is Segmented by Type (Thermal Beam, Epithermal Beam), by Application (Brain Tumor, Extracranial Tumor). BANGALORE, India, Feb. 28, 2025 /PRNewswire/ ...

Memorial Regional Hospital South Pioneers Voice-Activated Smart Control Solution for Patients with Spinal Injuries

PR Newswire HOLLYWOOD, Fla., Feb. 28, 2025 Memorial Rehabilitation Institute is the first in the U.S. to implement Hatchmed SmartHub powered by Aiva HOLLYWOOD, Fla., Feb. 28, 2025 /PRNewswire-PRWeb/ -- For individuals recovering from a ...

Disposable Gloves Market Size to Reach a Value of US$17.66 Billion by 2031, The Insight Partners

PR Newswire NEW YORK, Feb. 28, 2025 NEW YORK, Feb. 28, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the disposable gloves market share is expected to reach US$ 17.66 billion by 2031 from US$ 7.08 ...

Government of Canada takes further action to combat fentanyl production and organized crime

Canada NewsWire OTTAWA, ON, Feb. 28, 2025 OTTAWA, ON, Feb. 28, 2025 /CNW/ - The Minister of Mental Health and Addictions and Associate Minister of Health, Minister of Public Safety, and the Fentanyl Czar today announced new measures to ...

New independent studies show that ColdZyme addresses the root cause of respiratory infections, reducing sick days and symptoms

PR Newswire STOCKHOLM, Feb. 28, 2025 STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- Today, results from two independent studies on the medical device ColdZyme were published in the peer-reviewed scientific journal The Journal of Physiology. The ...

HIV Diagnosis Market to Hit USD 5.31 Billion by 2030 with 10.3% CAGR | MarketsandMarkets™

PR Newswire DELRAY BEACH, Fla., Feb. 28, 2025 DELRAY BEACH, Fla., Feb. 28, 2025 /PRNewswire/ -- The global HIV diagnosis market, valued at US$2.96 billion in 2024, is forecasted to grow at a robust CAGR of 10.3%, reaching US$3.25 billion in ...

Physical activity linked to lower risk of dementia, sleep disorders, other diseases

PR Newswire MINNEAPOLIS, Feb. 28, 2025 MINNEAPOLIS, Feb. 28, 2025 /PRNewswire/ -- People who get moderate to vigorous physical activity may be less likely to develop dementia, stroke, anxiety, depression, and sleep disorders, according to a ...

Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT001, a Novel Multi-Targeting, Half-Life Extended Bispecific Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Skin Diseases

PR Newswire BOSTON, Feb. 28, 2025 Preclinical data with BBT001 demonstrate its best-in-disease potential for improved efficacy and dosing convenience compared to approved biologics in atopic dermatitis Interim safety and pharmacokinetic ...

March of Dimes: Measles Outbreak in Texas Claims the Life of a Child, Underscoring the Urgent Need for Immunization

PR Newswire ARLINGTON, Va., Feb. 28, 2025 ARLINGTON, Va., Feb. 28, 2025 /PRNewswire/ -- An unvaccinated school-aged child in Texas has tragically died from measles, marking the first measles-related death in the US since 2015. This case is ...

Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS Delivery

PR Newswire BOSTON and NEW YORK, Feb. 28, 2025 BOSTON and NEW YORK, Feb. 28, 2025 /PRNewswire/ -- Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy solutions, supports the Broad Institute of MIT and Harvard, ...

Q32 Bio Announces Late-Breaking Presentation of Results from SIGNAL-AA Part A Clinical Trial of Bempikibart in Alopecia Areata at the 2025 American Academy of Dermatology Annual Meeting

PR Newswire WALTHAM, Mass., Feb. 28, 2025 -- Oral presentation to highlight Phase 2a Part A results of the randomized, placebo-controlled SIGNAL-AA clinical trial evaluating bempikibart in patients with severe and very severe alopecia areata ...

Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)

PR Newswire EAST HANOVER, N.J., Feb. 28, 2025 EAST HANOVER, N.J., Feb. 28, 2025 /PRNewswire/ -- Novartis announced today it will present data from 17 abstracts, including investigator-initiated trials, across its immunology ...

Avidity Biosciences Honors Rare Disease Day® and Global Efforts to Support People and Families Impacted by Rare Neuromuscular Diseases

PR Newswire SAN DIEGO, Feb. 28, 2025 SAN DIEGO, Feb. 28, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide ...

Biolabs International LLC Announces Its Successful Launch of SpeedySwab™ Rapid COVID-19 + FLU A&B Antigen Self-Test and Their New AI-Driven Diagnostics App Amid the Most Severe Flu Season Since 2009

PR Newswire SAN DIEGO, Feb. 28, 2025 SAN DIEGO, Feb. 28, 2025 /PRNewswire/ -- The United States is currently facing its most severe flu season since 2009, according to the latest data from the Centers for Disease Control and Prevention ...

AANP Applauds Legislation to Improve Care for Patients With Diabetes

PR Newswire AUSTIN, Texas, Feb. 28, 2025 AUSTIN, Texas, Feb. 28, 2025 /PRNewswire/ -- The American Association of Nurse Practitioners® (AANP) applauds the introduction of The Promoting Access to Diabetic Shoes Act by Representatives Darin ...

New Survey Offers Detailed View of Short- and Long-Term Burden of Guillain-Barré Syndrome

PR Newswire CONSHOHOCKEN, Pa., Feb. 28, 2025 CONSHOHOCKEN, Pa., Feb. 28, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International today released new survey data illustrating how people with Guillain-Barré Syndrome experience this ...

Mediaplanet Launches 2025 Rare Diseases Campaign on Rare Disease Day

PR Newswire NEW YORK, Feb. 28, 2025 Launching today on Rare Disease Day in USA TODAY and online, Mediaplanet's Rare Diseases campaign sparks vital conversations by sharing the personal stories of those impacted and educating the public on ...

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor

PR Newswire INDIANAPOLIS, Feb. 28, 2025 The positive opinion is based on results from the Phase 3 BRUIN CLL-321 trial, recently presented at the 2024 American Society of Hematology Annual Meeting BRUIN CLL-321 is the first randomized ...

The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU

PR Newswire STOCKHOLM, Feb. 28, 2025 STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP) of the ...

U.S. FDA Approves Label Expansion for ALK's ODACTRA® (House Dust Mite Allergen Tablet) for Sublingual Use as Immunotherapy to Now Include Children with House Dust Mite Allergy

PR Newswire BEDMINSTER, N.J., Feb. 28, 2025 - ODACTRA is now indicated to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in children ages 5 through 11 years, in addition to patients 12 through 65 years ...

BIMZELX® (bimekizumab) Negotiations with pCPA Concluded Successfully Following Positive CDA and INESSS Recommendations for Adults with Active Psoriatic Arthritis and Adults with Active Ankylosing Spondylitis

Canada NewsWire OAKVILLE, ON, Feb. 28, 2025 Positive CDA and INESSS reimbursement recommendations are an important step towards public access to BIMZELX®, the first and only treatment approved by Health Canada for eligible patients with ...

Latest Press Releases

Premium Press Releases »

Press Releases »

Medindia Newsletters

Latest Press Releases

Follow Us On :